Rituximab Improves Subclinical Temporal Dispersion of Distal Compound Muscle Action Potential in Anti-MAG/SGPG Neuropathy Associated with Waldenström Macroglobulinemia: A Case Report
Patients with anti-myelin-associated glycoprotein (MAG)/sulfated glucuronyl paragloboside (SGPG) neuropathy associated with Waldenström macroglobulinemia show demyelinating neuropathy, but the temporal dispersion of distal compound muscle action potential (CMAP) in motor nerve conduction studies (NC...
Main Author: | Kanji Yamamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2013-02-01
|
Series: | Case Reports in Neurology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/348395 |
Similar Items
-
Beneficial Effect of Bendamustine in a Patient with Anti-MAG/SGPG Neuropathy and Bing-Neel Syndrome Associated with Waldenström Macroglobulinemia: A Case Report
by: Syugo Ueki, et al.
Published: (2018-03-01) -
Macroglobulinemia de Waldenström - remissão completa após tratamento com rituximabe Successful outcome in Waldenström's macroglobulinemia treated with rituximab
by: Flavia C. F. Pimenta, et al.
Published: (2008-10-01) -
An Autopsy Case of Amyotrophic Lateral Sclerosis with Waldenström Macroglobulinemia and Anti-MAG Gammopathy
by: Snejana Jurici, et al.
Published: (2011-12-01) -
Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
by: Jang Ho Cho, et al.
Published: (2021-05-01) -
Unusual presentation of Waldenstrom macroglobulinemia
by: Chih-Yu Chang, et al.
Published: (2018-03-01)